Lessons learned from a SIRT2-selective inhibitor. Editorial Article uri icon

Overview

publication date

  • April 26, 2016

Research

keywords

  • Antineoplastic Agents
  • Drug Evaluation, Preclinical
  • Histone Deacetylase Inhibitors
  • Molecular Targeted Therapy
  • Neoplasms
  • Sirtuin 2

Identity

PubMed Central ID

  • PMC5029603

Scopus Document Identifier

  • 84966539011

Digital Object Identifier (DOI)

  • 10.18632/oncotarget.8502

PubMed ID

  • 27050282

Additional Document Info

volume

  • 7

issue

  • 17